LifeVantage is a science-based network marketing company. It focuses on helping people achieve their health, wellness and financial independence goals. The Company provides products and a financially rewarding direct sales business opportunity to customers and independent distributors seeking a healthy lifestyle and financial freedom. LifeVantage engages in the identification, research, development and distribution of advanced nutraceutical dietary supplements and skin care products, including Protandim, its scientifically-validated dietary supplement; LifeVantage TrueScience, its line of anti-aging skin care products; Canine Health; Axio, its energy drink mixes, and PhysIQ.
Type
Public
HQ
Sandy, US
Founded
2003
Size (employees)
211 (est)
LifeVantage was founded in 2003 and is headquartered in Sandy, US
Report incorrect company information

LifeVantage Office Locations

LifeVantage has an office in Sandy
Sandy, US (HQ)
300 9785 S Monroe St
Show all (1)
Report incorrect company information

LifeVantage Financials and Metrics

LifeVantage Financials

LifeVantage's revenue was reported to be $206.54 m in FY, 2016 which is a 8.5% increase from the previous period.
USD

Revenue (Q3, 2017)

45 m

Gross profit (Q3, 2017)

36.8 m

Gross profit margin (Q3, 2017), %

81.7%

Net income (Q3, 2017)

61 k

EBIT (Q3, 2017)

223 k

Market capitalization (25-Apr-2018)

54.5 m

Cash (31-Mar-2017)

9.2 m

EV

47.3 m
LifeVantage's current market capitalization is $54.5 m.
Annual
USDFY, 2014FY, 2015FY, 2016

Revenue

214 m190.3 m206.5 m

Revenue growth, %

(11%)9%

Cost of goods sold

33.2 m28 m33.9 m

Gross profit

180.8 m162.3 m172.6 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Revenue

51.3 m51.5 m55.1 m51.6 m48.2 m45.2 m45.4 m52 m56.2 m54.9 m48.9 m45 m

Cost of goods sold

7.8 m7.9 m8.5 m5.7 m7.5 m7.6 m7 m7.8 m9.7 m8.8 m7.5 m8.2 m

Gross profit

43.5 m43.6 m46.6 m46 m40.8 m37.6 m38.4 m44.2 m46.4 m46.1 m41.4 m36.8 m

Gross profit Margin, %

85%85%85%89%84%83%85%85%83%84%85%82%
Annual
USDFY, 2014FY, 2015FY, 2016

Cash

20.4 m13.9 m7.9 m

Accounts Receivable

1.3 m1 m1.6 m

Inventories

8.8 m9.2 m25.1 m

Current Assets

40 m30.5 m42.4 m
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Cash

28 m34.5 m35.7 m22.1 m18.6 m15.4 m13.7 m15.8 m8.5 m10.2 m11.7 m9.2 m

Accounts Receivable

923 k873 k2.6 m1.7 m1.1 m1.3 m1.1 m1.7 m2 m1.4 m717 k1.2 m

Inventories

10.6 m9.8 m8.6 m11 m12.1 m10.9 m8.5 m10.6 m17 m23.9 m21.4 m19.1 m

Current Assets

44.9 m52.9 m56.3 m43.8 m38.6 m34.9 m30.9 m36.5 m35.7 m39.6 m36.7 m37.8 m
Annual
USDFY, 2014FY, 2015FY, 2016

Net Income

11.4 m7 m6 m

Depreciation and Amortization

2.1 m2.3 m1.9 m

Cash From Operating Activities

12.1 m13.2 m6 m

Purchases of PP&E

(1.9 m)(1.2 m)(562 k)
Quarterly
USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017

Net Income

3.3 m3.3 m2.5 m4.7 m1.5 m573 k1.1 m1.6 m1 m1.2 m283 k61 k

Depreciation and Amortization

499 k498 k530 k

Inventories

11 m12.1 m10.9 m8.5 m10.6 m17 m

Accounts Payable

4.2 m4 m2.7 m2.5 m5.9 m5.9 m7.7 m5 m6.5 m
USDY, 2017

EV/EBIT

212 x

Revenue/Employee

216.4 k

Financial Leverage

3.4 x
Show all financial metrics
Report incorrect company information